TABLE 4.
Isolates temporally collected from a single patient
Organism | Isolate | Date collected | Source | Imipenem MICa | blaKPC PCR |
---|---|---|---|---|---|
E. cloacae | MNCRE41 | March 10 | Sputum | 8, R | + |
E. coli | MNCRE46 | April 11 | Urine | 2, I; 4, R (ms) | + |
E. coli | MNCRE47 | April 11 | Sputum | ≤1, S | − |
E. coli | MNCRE45 | April 11 | Urine | ≥16, R | + |
E. coli | MNCRE44 | April 13 | Sputum | ≤1, S (≥16, Rb) | + |
E. cloacae | MNCRE51 | May 1 | Sputum | 8, R | + |
MIC values (in micrograms per milliliter) were reported by the submitting clinical laboratories using Vitek 2 (bioMérieux) automated susceptibility analysis, with the exception of the entry labeled ms, which represents a MicroScan (Siemens Healthcare Diagnostics) automated susceptibility testing result. Letters after numbers indicate resistance status: R, resistant; I, intermediate; S, susceptible.
Due to the initial carbapenem-susceptible result in an otherwise highly drug-resistant MIC profile, isolate MNCRE44 was retested using broth microdilution to confirm a carbapenem-resistant phenotype.